Sponsored by   Mudabala
 
 
BETA
Loading Loading ...
Sat, 20 Mar 2010 | 07:06 GMT
Sat, Mar 20, 2010, 07:06 GMT
 
 
  Société de Therapeutique Marocaine 
Last Price   MAD 1,150.00    -2.54%   19Mar10
 
IPO Facts
  • Type of Offering
  • IPO
  • Status
  • Listed
  • Exchange
  • Casablanca SE
  • Sector
  • Health Care
  • Country of Incorporation
  • Morocco
  • Shares Offered
  • 150,000
  • Offer Size
  • MAD 102.00M
  • Percentage Offered
  • 15%
  • Issue Price
  • MAD 680.00
  • Eligibility Requirements
    Open to all subscribers residing both inside or outside of Morocco:

    Type I: Employees of Sothema : 3,000 shares representing 2% of the offer or 0.3% of the capital.
    Type II: Applicants subscribing to less than MAD 2 M: 55,000 shares representing 37% of the offer or 5.5% of the capital.
    Type III: Applicants subscribing to more than MAD 2 M: 81,800 shares representing 54% of the offer or 8.18% of the capital.
    Type IV: Pharmacists: 10,200 shares representing 7% of the offer or 1.02% of the capital.
 
  • Additional Information
    Offer Price: Between MAD 630-720 ; the Price was fixed at MAD 680 after subscription.
 
 
Key Dates
  • Open Date
  • 07Feb05
  • Closing Date
  • 14Feb05
  • Listing Date
  • 21Feb05
 
Advisors
  • Legal Advisor
  • FIGES
  • Auditors
  • Fiduciaire Des Societes Marocaines
  • Receiving Banks
    Lead Receiving Bank: CFG Marches

    Co-lead Receiving Bank: BMCE Capital Bourse

    Dar Tawfir, BMCE Bank
 
 
News & Reports
STOCK PERFORMANCE
 
» Charting
Last Price 19Mar10
MAD1,150.00
Change
  30.00 ( 2.54%)
Year High / Low
MAD 1,198.00 - 940.00
Market Cap
MAD 1,380.00M
 
Performance Overview
  • Over-subscription
  • 7.25 x
  • First Day Open / Close
  • 840.00 / 840.00
  • First Day High / Low
  • 840.00 / 840.00
  • 1st Day Change
  • 0.00%
  • 1st Month Change
  • + 0.24%
  • Change Since Floatation
  • + 36.91%
 
 
 
 
 
 
 
 

Site is optimised for viewing at 1024 x 768 with Internet Explorer v6 and Firefox v3.0 and above.
Copyright © 2010 ABQ Zawya Ltd. All rights reserved. Please read our Membership Agreement